(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 26.54%5.53B | 30.93%3.62B | 33.36%1.7B | 31.94%5.95B | 27.50%4.37B | 22.88%2.77B | --1.28B | 5.92%4.51B | --3.43B | 15.00%2.25B |
Operating income | 26.54%5.53B | 30.93%3.62B | 33.36%1.7B | 31.94%5.95B | 27.50%4.37B | 22.88%2.77B | 1.28B | 5.92%4.51B | 3.43B | 15.00%2.25B |
Cost of sales | -17.96%-926M | -18.26%-611.97M | -19.53%-295.44M | -40.40%-1.06B | -42.09%-785.02M | -47.19%-517.49M | ---247.16M | -36.10%-754.86M | ---552.47M | -40.61%-351.58M |
Operating expenses | -17.96%-926M | -18.26%-611.97M | -19.53%-295.44M | -40.40%-1.06B | -42.09%-785.02M | -47.19%-517.49M | -247.16M | -36.10%-754.86M | -552.47M | -40.61%-351.58M |
Gross profit | 28.42%4.61B | 33.85%3.01B | 36.68%1.41B | 30.24%4.89B | 24.70%3.59B | 18.38%2.25B | 1.03B | 1.40%3.76B | 2.88B | 11.25%1.9B |
Selling expenses | -5.71%-1.65B | -2.18%-1.12B | 7.88%-579.27M | 0.48%-1.99B | -18.12%-1.56B | -19.37%-1.1B | ---628.84M | -3.00%-2B | ---1.32B | 20.03%-921.9M |
Administrative expenses | -39.37%-818.11M | -44.65%-531.68M | -64.33%-270.47M | -12.80%-811.79M | -24.34%-587M | -16.31%-367.57M | ---164.59M | 63.85%-719.7M | ---472.1M | 81.93%-316.04M |
Research and development expenses | -23.54%-1.38B | -30.38%-911.3M | -40.38%-467.57M | -30.51%-1.54B | -25.29%-1.11B | -16.80%-698.98M | ---333.07M | -43.89%-1.18B | ---888.66M | -44.64%-598.43M |
Special items of operating profit | -11.73%26.58M | 23.84%21.1M | -33.07%12.59M | 101.11%35.39M | 111.39%30.11M | 58.57%17.04M | --18.81M | 17.48%17.6M | --14.25M | 40.30%10.74M |
Operating profit | 120.89%792.39M | 372.93%462.2M | 234.02%103.59M | 548.56%580.97M | 70.03%358.72M | 33.83%97.73M | -77.3M | 87.50%-129.52M | 210.97M | 104.56%73.03M |
Financing income | ---- | ---- | ---- | ---- | 88.26%146.87M | ---- | ---- | 1,557.24%161.33M | --78.01M | 502.07%24.19M |
Special items of earning before tax | 50.50%505.31M | 8.19%309.44M | 18.11%155.83M | 652.28%640.82M | 647.26%335.74M | 10,425.20%286.01M | --131.94M | 466.45%85.18M | --44.93M | -142.97%-2.77M |
Earning before tax | 54.24%1.3B | 101.08%771.64M | 374.81%259.42M | 944.30%1.22B | 151.96%841.33M | 306.31%383.74M | 54.64M | 111.57%117M | 333.91M | 105.94%94.44M |
Tax | -138.42%-174.89M | -171.62%-112.67M | 19.47%-17.7M | -1,157.01%-122.57M | -75.18%-73.35M | -193.71%-41.48M | ---21.97M | 83.62%-9.75M | ---41.87M | ---14.12M |
After-tax profit from continuing operations | 46.20%1.12B | 92.54%658.97M | 640.05%241.72M | 924.96%1.1B | 162.97%767.98M | 326.12%342.26M | 32.66M | 110.01%107.25M | 292.04M | 105.05%80.32M |
Earning after tax | 46.20%1.12B | 92.54%658.97M | 640.05%241.72M | 924.96%1.1B | 162.97%767.98M | 326.12%342.26M | 32.66M | 110.01%107.25M | 292.04M | 105.05%80.32M |
Minority profit | ---12.26M | ---7.71M | ---3.23M | ---9K | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 47.80%1.14B | 94.79%666.68M | 649.93%244.95M | 924.97%1.1B | 162.97%767.98M | 326.12%342.26M | 32.66M | 108.68%107.25M | 292.04M | 104.58%80.32M |
Basic earnings per share | 45.45%1.28 | 92.31%0.75 | 600.00%0.28 | 950.00%1.26 | 158.82%0.88 | 333.33%0.39 | 0.04 | 105.15%0.12 | 0.34 | 100.76%0.09 |
Diluted earnings per share | 45.88%1.24 | 92.11%0.73 | 575.00%0.27 | 916.67%1.22 | 165.63%0.85 | 322.22%0.38 | 0.04 | 105.15%0.12 | 0.32 | 100.76%0.09 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data